Healthcare provider profile · identity verified

Richard A Kader, D.O.

Allopathic & Osteopathic Physicians|Family Medicine · LINWOOD, NJ · NPI 1003983594

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Richard A Kader, D.O. received $155.74 in general payments during 2025 across 2 reported records.

HEARTFLOW, INC. accounted for 71.1% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 1 associated product.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 57 claims for Jardiance by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 28 claims for Mounjaro by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 50 claims for Trulicity by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$155.74

2 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
HEARTFLOW, INC.	Unresolved — no canonical attribution shown	$110.74	71.1%	1	2025
Lilly USA, LLC	Unresolved — no canonical attribution shown	$45.00	28.9%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$110.74	1
Education	$45.00	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
FFRct Normalized: ffrct	Device	HEARTFLOW, INC.	$110.74	1	2025
Source payment records 2025-12-11 · HEARTFLOW, INC. · $110.74 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557	Jardiance · 2024 Exact normalized brand match · 1 Part D row	57	14
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	MOUNJARO open payments reported associated product	CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455	Mounjaro · 2024 Exact normalized brand match · 1 Part D row	28	suppressed by CMS
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	TRULICITY open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601	Trulicity · 2024 Exact normalized brand match · 1 Part D row	50	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1102	315
Amlodipine Besylate	Amlodipine Besylate	643	175
Levothyroxine Sodium	Levothyroxine Sodium	485	139
Metoprolol Succinate	Metoprolol Succinate	436	130
Metformin Hcl	Metformin Hcl	367	103
Pantoprazole Sodium	Pantoprazole Sodium	354	108
Lorazepam	Lorazepam	319	71
Alprazolam	Alprazolam	316	68
Zolpidem Tartrate	Zolpidem Tartrate	270	52
Sertraline Hcl	Sertraline Hcl	262	64
Omeprazole	Omeprazole	241	74
Rosuvastatin Calcium	Rosuvastatin Calcium	237	71
Tramadol Hcl	Tramadol Hcl	231	55
Escitalopram Oxalate	Escitalopram Oxalate	228	62
Clonazepam	Clonazepam	210	34
Lisinopril	Lisinopril	210	56
Tamsulosin Hcl	Tamsulosin Hcl	208	54
Doxycycline Hyclate	Doxycycline Hyclate	206	153
Gabapentin	Gabapentin	204	60
Losartan Potassium	Losartan Potassium	201	65
Albuterol Sulfate Hfa	Albuterol Sulfate	195	86
Prednisone	Prednisone	177	97
Azithromycin	Azithromycin	167	127
Famotidine	Famotidine	167	57
Hydrochlorothiazide	Hydrochlorothiazide	166	51
Eliquis	Apixaban	143	30
Glimepiride	Glimepiride	141	39
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	137	41
Methylprednisolone	Methylprednisolone	136	113
Olmesartan Medoxomil	Olmesartan Medoxomil	118	32
Furosemide	Furosemide	114	41
Donepezil Hcl	Donepezil Hcl	112	24
Trazodone Hcl	Trazodone Hcl	102	34
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	101	82
Allopurinol	Allopurinol	98	24
Atenolol	Atenolol	98	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	93	25
Esomeprazole Magnesium	Esomeprazole Magnesium	91	23
Januvia	Sitagliptin Phosphate	90	19
Fluticasone Propionate	Fluticasone Propionate	89	34
Naproxen	Naproxen	87	37
Potassium Chloride	Potassium Chloride	86	27
Metoprolol Tartrate	Metoprolol Tartrate	85	29
Clopidogrel	Clopidogrel Bisulfate	83	27
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	76	24
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	75	57
Celecoxib	Celecoxib	74	19
Carvedilol	Carvedilol	73	22
Synthroid	Levothyroxine Sodium	73	22
Meloxicam	Meloxicam	71	18
Pravastatin Sodium	Pravastatin Sodium	70	20
Ibuprofen	Ibuprofen	68	19
Ketoconazole	Ketoconazole	68	37
Citalopram Hbr	Citalopram Hydrobromide	67	17
Xarelto	Rivaroxaban	65	15
Montelukast Sodium	Montelukast Sodium	64	20
Bupropion Xl	Bupropion Hcl	62	20
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	59	13
Duloxetine Hcl	Duloxetine Hcl	59	13
Oxycodone Hcl	Oxycodone Hcl	59	15
Diazepam	Diazepam	58	12
Ezetimibe	Ezetimibe	58	17
Fenofibrate	Fenofibrate Nanocrystallized	58	15
Mirtazapine	Mirtazapine	58	12
Ondansetron Hcl	Ondansetron Hcl	58	25
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	58	17
Jardiance	Empagliflozin	57	14
Ozempic	Semaglutide	55	15
Valacyclovir	Valacyclovir Hcl	55	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	28
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	53	39
Ondansetron Odt	Ondansetron	53	11
Hydralazine Hcl	Hydralazine Hcl	52	16
Ramipril	Ramipril	51	16
Topiramate	Topiramate	50	11
Trulicity	Dulaglutide	50	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	50	15
Myrbetriq	Mirabegron	49	14
Paxlovid	Nirmatrelvir/Ritonavir	49	49
Fluoxetine Hcl	Fluoxetine Hcl	46	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	46	14
Meclizine Hcl	Meclizine Hcl	46	22
Paroxetine Hcl	Paroxetine Hcl	44	15
Fluconazole	Fluconazole	43	21
Ipratropium Bromide	Ipratropium Bromide	42	suppressed
Spironolactone	Spironolactone	42	11
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	40	12
Simvastatin	Simvastatin	39	14
Finasteride	Finasteride	38	suppressed
Diclofenac Sodium	Diclofenac Sodium	37	suppressed
Torsemide	Torsemide	37	15
Cephalexin	Cephalexin	36	25
Oxybutynin Chloride	Oxybutynin Chloride	36	suppressed
Enalapril Maleate	Enalapril Maleate	35	suppressed
Memantine Hcl	Memantine Hcl	35	suppressed
Levetiracetam	Levetiracetam	34	suppressed
Propranolol Hcl Er	Propranolol Hcl	34	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Irbesartan	Irbesartan	33	suppressed
Mometasone Furoate	Mometasone Furoate	33	25
Tizanidine Hcl	Tizanidine Hcl	33	14
Tolterodine Tartrate Er	Tolterodine Tartrate	33	suppressed
Desloratadine	Desloratadine	32	suppressed
Lansoprazole	Lansoprazole	32	11
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	31	suppressed
Clonidine Hcl	Clonidine Hcl	30	suppressed
Glipizide	Glipizide	30	suppressed
Mupirocin	Mupirocin	30	23
Sucralfate	Sucralfate	30	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	29	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	28	suppressed
Levofloxacin	Levofloxacin	28	21
Mounjaro	Tirzepatide	28	suppressed
Bydureon Bcise	Exenatide Microspheres	27	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	11
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Terazosin Hcl	Terazosin Hcl	25	suppressed
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Baclofen	Baclofen	24	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	11
Indapamide	Indapamide	23	suppressed
Procto-Med Hc	Hydrocortisone	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	suppressed
Invokana	Canagliflozin	21	suppressed
Oxcarbazepine	Oxcarbazepine	21	suppressed
Pregabalin	Pregabalin	21	12
Sotalol	Sotalol Hcl	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Labetalol Hcl	Labetalol Hcl	20	suppressed
Metolazone	Metolazone	20	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Ammonium Lactate	Ammonium Lactate	18	suppressed
Felodipine Er	Felodipine	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Lidocaine	Lidocaine	18	suppressed
Naltrexone Hcl	Naltrexone Hcl	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Erythromycin	Erythromycin Base	17	15
Flecainide Acetate	Flecainide Acetate	17	suppressed
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	16	suppressed
Hydrocortisone	Hydrocortisone	16	13
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Risperidone	Risperidone	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Glyburide-Metformin Hcl	Glyburide/Metformin Hcl	15	suppressed
Risedronate Sodium	Risedronate Sodium	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Amoxicillin	Amoxicillin	14	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Valsartan	Valsartan	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Mesalamine	Mesalamine	13	suppressed
Metronidazole	Metronidazole	13	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Colchicine	Colchicine	12	suppressed
Dextroamphetamine Sulfate Er	Dextroamphetamine Sulfate	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Lactulose	Lactulose	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Niacin Er	Niacin	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Gemfibrozil	Gemfibrozil	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$155.74 · 2 records	HEARTFLOW, INC.	FFRct	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error